Achieved sequential improvement in profitability and free cash flow ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, Matt Monaghan, chairman, president, and chief executive officer, said “In 2Q22, we achieved sequential revenue growth of 4.7% in mobility … [Read more…]
OXFORD, England & PASADENA, Calif.–(BUSINESS WIRE)–$RKLY #boardofdirectors–Rockley Photonics (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Richard Kuntz, M.D., M.Sc., to its board of directors. Dr. Kuntz will join the board as an independent director, effective August 8, 2022. “We are delighted to welcome Richard Kuntz … [Read more…]
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, today announced the appointment of Scott T. Rottinghaus, M.D., as Senior Vice President and Chief Medical Officer, effective today, August 8, 2022. With over 20 years of experience in drug development … [Read more…]
Second Quarter Results Show Significant Sequential Improvement in Profitability Reduced Cash Usage by More than $30 Million Compared to First Quarter 2022 Strong Growth Compared to 2019 Pre-COVID Baseline: Total Digital and Nutritional Subscriptions +26%, Average Digital Retention +40BPS, Total Streams +22%, DAU/MAU +140BPS Secured $50 Million in Debt Financing EL SEGUNDO, Calif.–(BUSINESS WIRE)–The Beachbody … [Read more…]
SANTA BARBARA, Calif.–(BUSINESS WIRE)–Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2022. Second Quarter Highlights and Outlook Strong momentum with second quarter worldwide sales of $41.2 million, … [Read more…]
From acclaimed Maine playwright Michael Gorman of the famed La MaMa Theatre in N.Y.C., comes a NEW ground-breaking Blues Opera and epic tale of addiction, obsession, and recovery. AUGUSTA, Maine–(BUSINESS WIRE)–In a tale that stretches across generations and ancients—lost mariners, lost souls, lost lives—“The Ahab Inside Me” is a provocative new musical theater production that … [Read more…]
CLEVELAND–(BUSINESS WIRE)–#Biomedevice–Lazurite™ has been selected by The Healthcare Technology Report as one of the Top 100 Healthcare Technology Companies of 2022. The Healthcare Technology Report (“The Report”) provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. “The awardees on this year’s list represent the … [Read more…]
TEL AVIV, Israel–(BUSINESS WIRE)–Variscite, a leading worldwide provider of System on Modules (SoMs), today announced increasing traction with medical device companies needing highly trusted hardware and software designed for longevity. Variscite has become a premier provider in this space by satisfying stringent healthcare industry requirements and objectives while overcoming supply chain challenges that have plagued … [Read more…]
Provides parents with a voice and opportunity to tell Facebook, Instagram, Snapchat and TikTok that they do not consent to their kids’ use of these social media products SEATTLE–(BUSINESS WIRE)–Social Media Victims Law Center (SMVLC), a legal resource for parents of children harmed by social media addiction and abuse, has launched its “No Parental Consent … [Read more…]
STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA–Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock (or common stock equivalents in lieu thereof), together with Series A warrants to purchase up … [Read more…]
